Evolus Warned Over Misbranding in Social Media Promo for Frown Lines Drug
The FDA has warned Evolus that an Instagram post for Jeuveau is false or misleading and misbrands the drug.
Share
Why It Matters
Evolus posted an Instagram ad that the FDA said was false or misleading about their drug Jeuveau. When regulators warn a company about ads, it means they need to be more careful going forward.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.